文献速递青光眼眼底病与葡萄膜炎

近视合并原发性开角型青光眼患者视野缺损进展影响因素分析

[Analysis of factors affecting the progression of visual field defects in patients with myopia and primary open-angle glaucoma].
PubMed 文献 · Zhonghua Yan Ke Za Zhi · 2024-01-01

该双向性队列研究纳入中山大学中山眼科中心2006年1月至2024年1月近视合并原发性开角型青光眼患者106例182只眼,分析视野缺损进展的影响因素。结果显示年龄大、眼压波动大、基线中期视野缺损和基线中心视野缺损是进展的危险因素,且中低度近视与高度近视亚组的影响因素存在差异。

要点

  • 年龄大、眼压波动大、基线中期视野缺损和基线中心视野缺损与视野缺损进展相关。
  • 中低度近视亚组中,基线中心视野缺损、最佳矫正视力低和年龄大与进展风险增加相关。
  • 高度近视亚组中,基线中期视野缺损和眼压波动大与进展风险增加相关。

核心结论

  • 年龄、眼压波动、基线中期视野缺损和基线中心视野缺损是近视合并原发性开角型青光眼患者视野缺损进展的影响因素。
  • 不同近视程度患者视野缺损进展的影响因素存在差异。

研究设计与样本

  • 采用双向性队列研究设计,纳入2006年1月至2024年1月中山大学中山眼科中心青光眼门诊确诊的近视合并原发性开角型青光眼患者106例182只眼。
  • 根据功能性视野缺损进展标准分为进展组57只眼和无进展组125只眼,并按近视程度分为中低度近视眼亚组和高度近视眼亚组。
  • 采用广义估计方程进行组间比较,采用Cox比例风险模型分析视野缺损进展的影响因素。

主要发现

  • 进展组年龄43(29,53)岁、最佳矫正视力0.05(0.00,0.17)、眼压波动1.8(1.3,2.9)mmHg、基线中心视野缺损占52.6%(30/57)、视野模式标准差8.92(5.32,12.00)dB、视野指数77%(67%,88%)、使用3种降眼压药物者占35.1%(20/57),与无进展组比较差异均有统计学意义(均P<0.05)。
  • 多因素Cox比例风险模型显示,基线中期视野缺损(HR=2.33,95%CI:1.25~4.36,P=0.008)、基线中心视野缺损(HR=2.09,95%CI:1.11~3.93,P=0.022)、年龄大(模型A:HR=1.03,95%CI:1.00~1.05,P=0.017;模型B:HR=1.02,95%CI:1.00~1.05,P=0.019)和眼压波动大(模型A:HR=1.54,95%CI:1.32~1.81,P<0.001;模型B:HR=1.49,95%CI:1.26~1.75,P<0.001)与视野缺损进展相关。
  • 在中低度近视眼亚组,视野缺损进展风险增加与基线中心视野缺损(HR=5.74,95%CI:1.72~19.20,P=0.005)、最佳矫正视力低(模型A:HR=15.80,95%CI:2.07~121.00,P=0.008;模型B:HR=12.50,95%CI:2.65~58.70,P=0.001)、年龄大(模型A:HR=1.05,95%CI:1.02~1.08,P=0.002;模型B:HR=1.07,95%CI:1.03~1.11,P<0.001)相关。
  • 在高度近视眼亚组,视野缺损进展风险增加与基线中期视野缺损(HR=2.35,95%CI:1.12~4.92,P=0.024)、眼压波动大(模型A:HR=1.50,95%CI:1.24~1.82,P<0.001;模型B:HR=1.52,95%CI:1.26~1.83,P<0.001)相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the factors affecting the progression of visual field defects in patients with myopia and primary open-angle glaucoma (POAG), and to clarify whether the factors vary in patients with different degrees of myopia. Method: An ambispective cohort study was conducted among patients diagnosed with myopia and POAG from the glaucoma outpatient department at the Zhongshan Ophthalmic Center of Sun Yat-sen University between January 2006 and January 2024. Based on the criteria of functional visual field progression, patients were divided into the progression group and non-progression group, and further divided into the low to moderate myopia subgroup and high myopia subgroup according to the degree of myopia. The patient age, gender, type of glaucoma (high tension glaucoma and normal tension glaucoma), spherical equivalent refraction, best corrected visual acuity (BCVA, recorded as the logarithm of the minimum angle of resolution), intraocular pressure (IOP), central corneal thickness, baseline visual field, history of ophthalmic surgery (corneal refractive surgery and glaucoma surgery), and number of anti-glaucoma medications were summarized. The generalized estimation equation was used for comparison between groups, and the Cox proportional hazards model was used to analyze the factors affecting the progression of visual field defects. Results: A total of 182 eyes from 106 patients were included in this study. There were 57 eyes in the progression group and 125 eyes in the non-progression group. Compared with the non-progression group, the progression group had the older age [43 (29, 53) years old], worse BCVA [0.05 (0.00, 0.17)], greater IOP fluctuation [1.8 (1.3, 2.9)mmHg(1 mmHg=0.133 kPa)], more common baseline central defects [52.6%(30/57)], higher visual field pattern standard deviations [8.92 (5.32, 12.00)dB], lower visual field index [77% (67%, 88%)], and more anti-glaucoma medications [35.1% (20/57) patients used three medications] (all P<0.05). The Cox proportional hazards models showed that the baseline moderate visual field defects [hazard ratio (HR)=2.33, 95% confidence interval (CI): 1.25 to 4.36, P=0.008], baseline central defects (HR=2.09, 95%CI: 1.11 to 3.93, P=0.022), older age (Model A, HR=1.03, 95%CI: 1.00 to 1.05, P=0.017; Model B, HR=1.02, 95%CI: 1.00 to 1.05, P=0.019), and greater IOP fluctuation (Model A, HR=1.54, 95%CI: 1.32 to 1.81, P<0.001; Model B, HR=1.49, 95%CI: 1.26 to 1.75, P<0.001) were risk factors for visual field progression. In the low to moderate myopia subgroup, the increased risk of progression was associated with baseline central defects (HR=5.74, 95%CI: 1.72 to 19.20, P=0.005), worse BCVA (Model A, HR=15.80, 95%CI: 2.07 to 121.00, P=0.008; Model B, HR=12.50, 95%CI: 2.65 to 58.70, P=0.001), and older age (Model A, HR=1.05, 95%CI: 1.02 to 1.08, P=0.002; Model B, HR=1.07, 95%CI: 1.03 to 1.11, P<0.001). In the high myopia subgroup, the increased risk of progression was associated with baseline moderate visual field defects (HR=2.35, 95%CI: 1.12 to 4.92, P=0.024) and greater IOP fluctuation (Model A, HR=1.50, 95%CI: 1.24 to 1.82, P<0.001; Model B, HR=1.52, 95%CI: 1.26 to 1.83, P<0.001). Conclusions: Age, IOP fluctuation, baseline moderate visual field defects, and baseline central defects were the factors affecting the progression of visual field defects in patients with myopia and POAG. There were differences in the influencing factors of visual field progression in patients with different degrees of myopia. 目的: 探讨近视眼合并原发性开角型青光眼(POAG)患者视野缺损进展的影响因素及其在不同近视程度患者中是否存在差异。 方法: 双向性队列研究。收集2006年1月至2024年1月在中山大学中山眼科中心青光眼门诊确诊的近视眼合并POAG患者及其临床资料。根据功能性视野缺损进展标准,将患者分为视野缺损进展组和无进展组,并进一步按照近视程度分为中低度近视眼亚组和高度近视眼亚组。记录患者的年龄、性别、青光眼类型(高眼压性和正常眼压性)、等效球镜度数、最佳矫正视力(以最小分辨角的对数表示)、眼压、中央角膜厚度、基线视野、眼科手术史(角膜屈光手术、抗青光眼手术)、使用降眼压药物数量。采用广义估计方程进行组间比较,采用Cox比例风险模型分析视野缺损进展的影响因素。 结果: 共纳入符合标准的近视眼合并POAG患者106例(182只眼),其中进展组57只眼,无进展组125只眼。进展组年龄大[43(29,53)岁]、最佳矫正视力差[0.05(0.00,0.17)]、眼压波动大[1.8(1.3,2.9)mmHg(1 mmHg=0.133 kPa)]、基线中心视野缺损常见[52.6%(30/57)]、视野模式标准差值高[8.92(5.32,12.00)dB]、视野指数低[77%(67%,88%)]、使用降眼压药物数量多[使用3种药物者占35.1%(20/57)],与无进展组比较,差异均有统计学意义(均P<0.05)。多因素Cox比例风险模型分析显示,基线中期视野缺损[风险比(HR)=2.33,95%置信区间(CI):1.25~4.36,P=0.008]、基线中心视野缺损(HR=2.09,95%CI:1.11~3.93,P=0.022)、年龄大(模型A:HR=1.03,95%CI:1.00~1.05,P=0.017;模型B:HR=1.02,95%CI:1.00~1.05,P=0.019)和眼压波动大(模型A:HR=1.54,95%CI:1.32~1.81,P<0.001;模型B:HR=1.49,95%CI:1.26~1.75,P<0.001)与视野缺损进展相关。在中低度近视眼亚组,视野缺损进展风险增加与基线中心视野缺损(HR=5.74,95%CI:1.72~19.20,P=0.005)、最佳矫正视力低(模型A:HR=15.80,95%CI:2.07~121.00,P=0.008;模型B:HR=12.50,95%CI:2.65~58.70,P=0.001)、年龄大(模型A:HR=1.05,95%CI:1.02~1.08,P=0.002;模型B:HR=1.07,95%CI:1.03~1.11,P<0.001)相关。而在高度近视眼亚组,视野缺损进展风险增加与基线中期视野缺损(HR=2.35,95%CI:1.12~4.92,P=0.024)、眼压波动大(模型A:HR=1.50,95%CI:1.24~1.82,P<0.001;模型B:HR=1.52,95%CI:1.26~1.83,P<0.001)相关。 结论: 年龄、眼压波动、基线中期视野缺损和基线中心视野缺损是近视眼合并POAG患者视野缺损进展的影响因素;不同近视程度患者视野缺损进展的影响因素存在差异。.

来源:Zhonghua Yan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Huang J, Ye LT, Luo N, et al. [Analysis of factors affecting the progression of visual field defects in patients with myopia and primary open-angle glaucoma]. Zhonghua Yan Ke Za Zhi. 2024. PMID: 39267552. doi:10.3760/cma.j.cn112142-20240424-00191

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。